SQI Diagnostics Inc V.SQD.H

Alternate Symbol(s): SQIDF

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc

<< Previous

Bullboard Posts

Next >>

Post by FactFinder1994on May 29, 2023 2:31pm

92 Views

Post# 35469034

Not if, but becoming more mainstream...building forward

Ex-vivo lung perfusion (EVLP110) is a novel technique invented at the University Health Network by a team led by Dr. Shaf Keshavjee and Dr. Marcelo Cypel. This approach to lung perfusion has revolutionized organ transplantation. As the procedure becomes more mainstream in complex surgical facilities, the need to build capacity in the health care system to provide care in this way is increasingly important. Led by an expert faculty of international recognition, the Michener Institute of Education at UHN is excited to partner with UHN and members of the University of Toronto Department of Surgery to host this first-of-its kind course.